{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:14:48Z","timestamp":1793650488082,"version":"4.5.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304057"],"award-info":[{"award-number":["82304057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073467"],"award-info":[{"award-number":["82073467"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20230435"],"award-info":[{"award-number":["BX20230435"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaad.2025.12.020","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:37:17Z","timestamp":1765211837000},"page":"1144-1150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study"],"prefix":"10.1016","volume":"94","author":[{"given":"Jundong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2S","key":"10.1016\/j.jaad.2025.12.020_bib1","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jaad.2023.05.049","article-title":"Janus kinase inhibitors for alopecia areata","volume":"89","author":"King","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.12.020_bib2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/bjd\/ljae385","article-title":"British association of dermatologists living guideline for managing people with alopecia areata 2024","volume":"192","author":"Harries","year":"2025","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.12.020_bib3","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1111\/ajd.14597","article-title":"Systemic treatment of moderate to severe alopecia areata in adults: updated Australian expert consensus statement","volume":"66","author":"Kushnir-Grinbaum","year":"2025","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.12.020_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaad.2024.09.072","article-title":"Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: week 152 data from BRAVE-AA2","volume":"92","author":"King","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.12.020_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jamadermatol.2024.2734","article-title":"Baricitinib withdrawal and retreatment in patients with severe alopecia areata: the BRAVE-AA1 randomized clinical trial","volume":"160","author":"King","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.12.020_bib6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/ijd.15917","article-title":"Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population","volume":"61","author":"AlMarzoug","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2025.12.020_bib7","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.13475","article-title":"Drug survival and long-term outcome of tofacitinib in patients with alopecia areata: a retrospective study","volume":"103","author":"Huang","year":"2023","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2025.12.020_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ajd.14325","article-title":"Real-world effectiveness and safety of tofacitinib for alopecia areata: a retrospective cohort study of 202 patients","volume":"65","author":"Cranwell","year":"2024","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.12.020_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2016.09.006","article-title":"Tofacitinib for the treatment of alopecia areata and variants in adolescents","volume":"76","author":"Craiglow","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.12.020_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaad.2016.09.007","article-title":"Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients","volume":"76","author":"Liu","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.12.020_bib11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bjd\/ljad011","article-title":"Successful dose reduction of dupilumab in atopic dermatitis","volume":"188","author":"Ardern-Jones","year":"2023","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.12.020_bib12","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1111\/jdv.18908","article-title":"Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: a safe and effective practice?","volume":"37","author":"Mastorino","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2025.12.020_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40257-025-00923-1","article-title":"Upadacitinib dose reduction regimen in elderly patients with atopic dermatitis, guided by treat-to-target consensus recommendations","volume":"26","author":"Tong","year":"2025","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.12.020_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/annrheumdis-2018-213271","article-title":"Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study","volume":"78","author":"Takeuchi","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2025.12.020_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-016-3490-8","article-title":"Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice","volume":"36","author":"Lenert","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.12.020_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000545704","article-title":"Investigation of the clinical remission course in ulcerative colitis from tofacitinib induction to tapering or withdrawal in Japanese patients: a single-center retrospective study","volume":"10","author":"Koroku","year":"2025","journal-title":"Inflamm Intest Dis"},{"key":"10.1016\/j.jaad.2025.12.020_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c5146","article-title":"Implementing shared decision making in the NHS","volume":"341","author":"Elwyn","year":"2010","journal-title":"BMJ"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225033523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225033523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:25:50Z","timestamp":1791879950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225033523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0190962225033523"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.12.020","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}